Drug Application Partner
Accelerate Your Drug Development Timeline to NDA
Looking to accelerate your drug candidates' development timeline to the New Drug Application (NDA) stage? Quotient Sciences' drug development experts are ready to help discuss your needs.
Quotient Sciences understand that getting molecules to proof-of-concept (POC) and new drug application (NDA) are key milestones in the development of a new drug candidate. That is why we offer our fully integrated capabilities including our unique Translational Pharmaceutics® platform to reach those milestones faster. From first-in-human testing to seamless drug product supply for patient trials and drug optimization, we operate a cost-effective process that accelerates molecules through key milestones, faster.
Accelerating Early Candidate Development
POC to NDA Partner
From your molecule discovery to proof-of-concept (POC) to New Drug Application (NDA), Quotient Sciences are well equipped to partner with you to accelerate your drug approval process and reach your key milestones.
We have over 30 years of success at simplifying the early development to proof-of-concept of molecules, a key milestone in the development of a new drug candidate. At the same time, we also understand the transition to POC & NDA needs to be fast and cost-effective.
Integrated Development Strategies
-
Formulation DevelopmentIntegrated Development Strategies, Part 2: Reformulating for clinical and commercial successBy Dr. Andy Lewis
-
Translational PharmaceuticsDoes Partnering with a Fully Integrated Services Provider Really Improve Your Molecule’s Chances of Clinical and Commercial Success?By Dr. Peter Scholes
-
Translational PharmaceuticsHow an Integrated Approach Can Accelerate the Development of Complex Drug ProgramsBy Dr. Aruna Railkar
-
Early DevelopmentIntegrated Development Strategies, Part 1: Leveraging clinical data to accelerate from first in human (FIH) to proof of concept (POC)By John McDermott
Contact our experts
Quotient Sciences can help address the most critical challenges in the drug development process from proof-of-concept to new drug application. Contact us today to learn how we can help accelerate your program.
Molecule to cure. Fast.
-
Accelerating TimelinesAccelerate your path to the clinic with Charles River & Quotient SciencesIntegrated strategies for accelerating from discovery to IND. Introducing the Charles River and Quotient Sciences Collaboration.
-
Integrated ProgramsTranslational Pharmaceutics®Quotient Sciences' own Translational Pharmaceutics® solution innovates the way you design and implement your drug development program.